Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|April 9, 2010
Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondiiChristopher P Hencken, Lorraine Jones-Brando, Claudia Bordón, et al.
The Journal of Parasitology|February 15, 2014
A thiazole derivative of artemisinin moderately reduces Toxoplasma gondii cyst burden in infected miceTracey L Schultz, Christopher P Hencken, Lauren E Woodard, et al.
The Journal of Infectious Diseases|December 1, 1977
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccineR H Gilman, R B Hornick, W E Woodard, et al.
Molecular Therapy. Methods & Clinical Development|October 28, 2025
Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectorsJennifer L Peek, Alan Rosales, Julie Qi, et al.
The Journal of Pathology|June 20, 2012
Loss of glutathione S-transferase A4 accelerates obstruction-induced tubule damage and renal fibrosisAnlin Liang, Yun Wang, Lauren E Woodard, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectorsJennifer L Peek, Alan Rosales, Julie Qi, et al.
Scientific Reports|August 25, 2018
Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionalityLauren E Woodard, Cindi L Dennis, Julie A Borchers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2025
Urine-derived stem cells display homing, incorporation, and regeneration in human organoid and mouse models of acute kidney injuryJulie Bejoy, Richard C Welch, Eddie S Qian, et al.
Stem Cell Research & Therapy|July 26, 2022
Podocytes derived from human induced pluripotent stem cells: characterization, comparison, and modeling of diabetic kidney diseaseJulie Bejoy, Justin M Farry, Jennifer L Peek, et al.
Genesis (New York, N.Y. : 2000)|February 21, 2020
CRISPR/Cas9 engineering of albino cystinuria Type A miceThomas M Beckermann, Richard C Welch, Felisha M Williams, et al.
Pageof 12